Kerala Ayurveda Appoints Samir Dhawan, Kshiti Ranjan Das, and Kodikannath Jayarajan To The Board
The Board of Directors of Kerala Ayurveda Limited has approved the appointment of Samir Dhawan and Kshiti Ranjan Das as Additional Directors designated as Non-Executive Independent Directors.
Mary Carmen Gasco-Buisson Appointed CEO of Unilever’s Prestige Division
Unilever has appointed Mary Carmen Gasco-Buisson, a former Pandora executive, as the new Chief Executive Officer (CEO) of its Prestige division.
Charles Schwab CEO of Walt Bettinger to Retire After 16 Years
Charles Schwab has announced that its long-time Chief Executive Officer (CEO), Walt Bettinger, will retire at the end of the year, and President Rick Wurster will follow him.
Gopalan Srinivasan Resigned As Independent Director Of PB Fintech Upon Joining Galaxy Health As MD & CEO
Gopalan Srinivasan has tendered his resignation as the Independent Director of PB Fintech Limited with effect from September 24, 2024, pursuant to his appointment as Managing Director and CEO of Galaxy Health Insurance Company Limited.
CEO Of Nike, John Donahoe, Is Set To Retire; Company Veteran Elliott Hill To Replace
John Donahoe, Chief Executive Officer (CEO) of Nike, will retire next month, marking another leadership change as the company navigates sluggish sales, the company announced on Thursday.
TD Bank’s CEO Bharat Masrani To Retire; Raymond Chun, Head of Canadian Banking To Take Over
On Thursday, TD Bank, Canada's second-largest bank, announced that its Chief Executive Officer (CEO) Bharat Masrani will retire next year.
RBI Approves Reappointment Of V. Vaidyanathan As MD & CEO Of IDFC First Bank
On September 19, the Reserve Bank of India (RBI) granted its approval for the reappointment of V. Vaidyanathan as Managing Director and Chief Executive Officer (MD & CEO) of IDFC First Bank Limited for three years, effective December 19, 2024.
Dr. Sridevi Khambhampaty Appointed As CEO Of Shilpa Biologicals
Dr. Sridevi Khambhampaty has been appointed as Chief Executive Officer (CEO) of Shilpa Biologicals Private Limited, a wholly owned subsidiary of Shilpa Medicare Limited, with effect from September 19, 2024.
Starbucks’ North America’s CEO Michael Conway Has Retired After 11 Years’ Stint
Starbucks announced on Monday that Michael Conway, Chief Executive Officer (CEO) of its North America division, has decided to retire after approximately 11 years with the company.
John Slaven, CEO Of Vedanta Aluminium, Resigns
John Slaven, CEO of Vedanta Aluminium, has resigned from his role, citing personal reasons.
